Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
US4692332A · kind A · utility
33Cited by
9References
4Claims
0Family size
Inventor
Key dates
| Filing date | Jan 18, 1985 |
| Grant date | Sep 8, 1987 |
| Priority date | — |
| Expiry date | Jan 18, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and composition for treating malignant neoplasia and acquired immune deficiency syndrome by once daily administration of a substance (such as human chorionic gonadotropin) characteristic of the tumor or acquired immune deficiency syndrome-afflicted cell in an amount less than the lowest amount necessary to provoke a humoral immune response, as exemplified by the existence of a negative wheal upon subcutaneous administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.